IL297033A - Pathogen diagnostic test - Google Patents
Pathogen diagnostic testInfo
- Publication number
- IL297033A IL297033A IL297033A IL29703322A IL297033A IL 297033 A IL297033 A IL 297033A IL 297033 A IL297033 A IL 297033A IL 29703322 A IL29703322 A IL 29703322A IL 297033 A IL297033 A IL 297033A
- Authority
- IL
- Israel
- Prior art keywords
- nucleic acid
- sequence
- coronavirus
- synthetic
- influenza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005996P | 2020-04-06 | 2020-04-06 | |
| US202063062406P | 2020-08-06 | 2020-08-06 | |
| US202163136449P | 2021-01-12 | 2021-01-12 | |
| US202163154571P | 2021-02-26 | 2021-02-26 | |
| PCT/US2021/025806 WO2021207091A1 (en) | 2020-04-06 | 2021-04-05 | Pathogen diagnostic test |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL297033A true IL297033A (en) | 2022-12-01 |
Family
ID=75675001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL297033A IL297033A (en) | 2020-04-06 | 2021-04-05 | Pathogen diagnostic test |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12129523B2 (https=) |
| EP (2) | EP4286538A3 (https=) |
| JP (1) | JP7801240B2 (https=) |
| KR (1) | KR20220164745A (https=) |
| CN (1) | CN115917002A (https=) |
| AU (1) | AU2021251703A1 (https=) |
| BR (1) | BR112022020143A2 (https=) |
| CA (1) | CA3179579A1 (https=) |
| IL (1) | IL297033A (https=) |
| MX (1) | MX2022012516A (https=) |
| WO (1) | WO2021207091A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230019965A (ko) * | 2020-06-22 | 2023-02-09 | 주식회사 씨젠 | 검체 내 타겟 핵산 서열 검출을 위한 준비물을 제공하는 방법 |
| CA3240812A1 (en) * | 2021-12-22 | 2023-06-29 | Carter BARGER | Quality control for reporter screening assays |
| US12553093B1 (en) * | 2025-03-26 | 2026-02-17 | Wolf of Zion, Inc. | Methods of detecting, identifying and quantifying wild spike protein and covid vaccine spike proteins |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7582740B2 (en) * | 2003-04-17 | 2009-09-01 | The Trustees Of Columbia University In The City Of New York | Methods and kits for detecting SARS-associated coronavirus |
| EP1957678B1 (en) | 2005-11-28 | 2012-06-13 | Ibis Biosciences, Inc. | Compositions for use in identification of adventitious contaminant viruses |
| CN101384730A (zh) * | 2005-12-23 | 2009-03-11 | 阿尔维德医药技术公司 | 用于传染病和癌症检测的分子信标成像的方法和应用 |
| US8354230B2 (en) * | 2007-12-21 | 2013-01-15 | Quest Diagnostics Investments Inc. | Multiplex detection assay for influenza and RSV viruses |
| EP2913402B1 (en) * | 2010-07-16 | 2017-10-18 | Tocagen Inc. | Retrovirus detection |
| WO2013006793A2 (en) | 2011-07-06 | 2013-01-10 | Quest Diagnostics Investments Incorporated | Direct amplification and detection of viral and bacterial pathogens |
| WO2016057749A1 (en) * | 2014-10-08 | 2016-04-14 | Theranos, Inc. | Methods and devices for real-time diagnostic testing (rdt) for ebola and other infectious diseases |
| JP6873921B2 (ja) * | 2015-05-18 | 2021-05-19 | カリウス・インコーポレイテッド | 核酸の集団を濃縮するための組成物および方法 |
| JP2017209036A (ja) * | 2016-05-24 | 2017-11-30 | 東洋紡株式会社 | 改良されたウイルス検出方法 |
| JP7167913B2 (ja) | 2017-04-26 | 2022-11-09 | 東洋紡株式会社 | ウイルスの検査方法およびウイルスの検査用キット |
| JP7796660B2 (ja) * | 2020-03-09 | 2026-01-09 | エフ． ホフマン－ラ ロシュ アーゲー | 重症急性呼吸器症候群コロナウイルス２（ｓａｒｓ－ｃｏｖ－２）、インフルエンザａ及びインフルエンザｂを検出するための組成物及び方法 |
| CN111494616A (zh) * | 2020-04-27 | 2020-08-07 | 重庆医科大学附属永川医院 | 一种新冠病毒免疫增强型基因疫苗及其制备方法 |
-
2021
- 2021-04-05 EP EP23201494.4A patent/EP4286538A3/en active Pending
- 2021-04-05 WO PCT/US2021/025806 patent/WO2021207091A1/en not_active Ceased
- 2021-04-05 JP JP2022560915A patent/JP7801240B2/ja active Active
- 2021-04-05 US US17/222,807 patent/US12129523B2/en active Active
- 2021-04-05 BR BR112022020143A patent/BR112022020143A2/pt unknown
- 2021-04-05 IL IL297033A patent/IL297033A/en unknown
- 2021-04-05 AU AU2021251703A patent/AU2021251703A1/en active Pending
- 2021-04-05 CA CA3179579A patent/CA3179579A1/en active Pending
- 2021-04-05 EP EP21721738.9A patent/EP4133103A1/en not_active Withdrawn
- 2021-04-05 CN CN202180040815.0A patent/CN115917002A/zh active Pending
- 2021-04-05 MX MX2022012516A patent/MX2022012516A/es unknown
- 2021-04-05 KR KR1020227037965A patent/KR20220164745A/ko active Pending
-
2024
- 2024-09-13 US US18/885,280 patent/US20250084492A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021207091A1 (en) | 2021-10-14 |
| MX2022012516A (es) | 2023-01-19 |
| JP2023520590A (ja) | 2023-05-17 |
| JP7801240B2 (ja) | 2026-01-16 |
| CN115917002A (zh) | 2023-04-04 |
| BR112022020143A2 (pt) | 2023-02-28 |
| EP4286538A3 (en) | 2024-03-20 |
| US12129523B2 (en) | 2024-10-29 |
| AU2021251703A1 (en) | 2022-11-10 |
| CA3179579A1 (en) | 2021-10-14 |
| EP4286538A2 (en) | 2023-12-06 |
| US20220356535A1 (en) | 2022-11-10 |
| EP4133103A1 (en) | 2023-02-15 |
| US20250084492A1 (en) | 2025-03-13 |
| KR20220164745A (ko) | 2022-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McNaughton et al. | Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV) | |
| US20250084492A1 (en) | Pathogen diagnostic test | |
| Yelagandula et al. | Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq | |
| Yang et al. | Direct metatranscriptome RNA-seq and multiplex RT-PCR amplicon sequencing on nanopore MinION–promising strategies for multiplex identification of viable pathogens in food | |
| Li et al. | High sensitivity detection of SARS-CoV-2 using multiplex PCR and a multiplex-PCR-based metagenomic method | |
| Li et al. | Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing | |
| US20150344977A1 (en) | Method And System For Detection Of An Organism | |
| Chaisi et al. | Evaluation of a real-time PCR test for the detection and discrimination of Theileria species in the African buffalo (Syncerus caffer) | |
| US20240279751A1 (en) | A rapid multiplex rpa based nanopore sequencing method for real-time detection and sequencing of multiple viral pathogens | |
| IL296945A (en) | Methods for the detection of sars-cov-2 | |
| US20240240267A1 (en) | Assays for detecting pathogens | |
| Rahman et al. | Development of a culture-independent whole-genome sequencing of Nipah virus using the MinION Oxford Nanopore platform | |
| Kia et al. | Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing | |
| Mukherjee et al. | Leveraging CRISPR-Cas-Enhanced isothermal amplification tools for quick identification of pathogens causing livestock diseases | |
| US20230374592A1 (en) | Massively paralleled multi-patient assay for pathogenic infection diagnosis and host physiology surveillance using nucleic acid sequencing | |
| US20260028669A1 (en) | Methods and compositions for nucleic acid analysis | |
| HK40097173A (en) | Pathogen diagnostic test | |
| Ge et al. | Preferential amplification of pathogenic sequences | |
| Meneguzzi et al. | Enriched Long-Read Sequencing of Co-circulating Viruses in Complex Samples | |
| Wolters et al. | Novel SARS-CoV-2 Whole-genome sequencing technique using Reverse Complement PCR enables easy, fast and accurate outbreak analysis in hospital and community settings | |
| Sena et al. | Identification and quantitation of multiple variants in RNA virus genomes | |
| Senan et al. | A rapid point-of-care population-scale dipstick assay to identify and differentiate SARS-CoV-2 variants in COVID-19-positive patients | |
| Lee | Evidence-Based Evaluation of PCR Diagnostics for SARS-Cov-2 and The Omicron Variants by Sanger Sequencing | |
| Mahony et al. | Improving bovine respiratory disease control through the characterisation of pathogen-host interactions | |
| Dai et al. | One-Seq: A Highly Scalable Sequencing-Based Diagnostic for SARS-CoV-2 and Other Single-Stranded Viruses |